Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-06-18, Stock:PFE, The news for the past five days is as follows:
2020-06-11: NEWS1: Sangamo Stock Avoids Biotech Pitfall On Pfizer-Partnered Gene Therapy.NEWS2: The Dow crashes more than 1,800 points out of nowhere — here's one reason why.NEWS3: Yahoo Finance Presents: White House Director of Trade and Manufacturing Policy Peter Navarro.NEWS4: AstraZeneca's R&D Spending Spikes 21% to Industry Best in 2019.NEWS5: Pfizer's Eczema Candidate Meets All Goals in Study on Teens.NEWS6: J&J to Begin Human Study on Coronavirus Vaccine in July.NEWS7: Moderna Will Start Testing Its Covid-19 Vaccine on 30,000 People in July.NEWS8: FDA Approves Pfizer’s Oncology Supportive Care Biosimilar, NYVEPRIA™ (pegfilgrastim-apgf).NEWS9: Pfizer Stock Falls 3%.
2020-06-12: NEWS1: Biotech Stocks Run Up In Coronavirus Drug Race, But Here's Another Way To Buy.NEWS2: U.S. FDA approves GSK unit's drug to treat infants and children with HIV.NEWS3: Mylan & Biocon's Semglee Wins FDA Approval for Diabetes.NEWS4: Pfizer Invites Public to View and Listen to Webcast of June 18 Conference Call with Analysts to Review Data Presentations at Scientific Conferences during the Week of June 15th.NEWS5: Pharma Stock Roundup: Coronavirus Updates From ABBV, LLY, JNJ, FDA Approvals.NEWS6: EU urges joint efforts by bloc's states to buy COVID-19 vaccines.NEWS7: AbbVie Jumped Into The Coronavirus Drug Hunt — Is AbbVie Stock A Buy?.
2020-06-15: NEWS1: Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know.NEWS2: UK funds human trials of potential COVID-19 vaccine from Imperial.NEWS3: Merck, Chevron share losses lead the way, but Dow flat.NEWS4: Germany Makes a Big Bet On a Covid-19 Vaccine Developer Once Coveted by Trump.NEWS5: Mylan N.V. -- Moody's: Upcoming debt financing brings Mylan/Upjohn one step closer to Viatris creation.NEWS6: Billions or trillions: The great coronavirus trade-off.
2020-06-16: NEWS1: Merck and Pfizer’s SGLT2 Inhibitor STEGLATROTM (ertugliflozin) Meets Primary Endpoint in VERTIS CV Trial for Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease.NEWS2: Moderna Is Racing Toward a Covid-19 Vaccine, but the Field Is Getting Crowded.NEWS3: Eli Lilly’s Cancer Drug Succeeded Where Pfizer Failed. What It Means for Their Stocks..NEWS4: U.S. narrows list of promising COVID-19 vaccine candidates to about 7.NEWS5: Pfizer Invites Public to View and Listen to Webcast of July 28 Conference Call with Analysts.NEWS6: Singapore scientists to start human trials of COVID-19 vaccine in August.
2020-06-17: NEWS1: Coronavirus update: States struggle to balance reopening with creeping rise in cases.NEWS2: Lilly Stock Has a 10% Upside, Guggenheim Says.NEWS3: Thirty-nine-year-old wife of Kentucky congressman dies suddenly.NEWS4: Merck's Steglatro Non-Inferior in Cardiovascular Outcomes Study.NEWS5: Upjohn Inc. -- Moody's assigns Baa3 unsecured rating to Upjohn/Viatris' US notes offering; outlook stable.NEWS6: EU calls for global alliance to buy COVID-19 vaccines up front.NEWS7: Lilly Gains as Verzenio Meets Early Breast Cancer Study Goal.NEWS8: Upjohn Finance B.V. -- Moody's assigns Baa3 unsecured rating to Upjohn/Viatris' Euro notes offering; outlook stable.NEWS9: Upjohn Finance B.V. -- Moody's assigns Baa3 first-time issuer ratings to Upjohn/Viatris; outlook stable.

Answer: Decrease